Hutchison China MediTech (NASDAQ:HCM) reported on Wednesday first quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Hutchison China MediTech announced earnings per share of $-0.32 on revenue of $57.28M. Analysts polled by anticipated EPS of $-0.32 on revenue of $57.26M. That with comparison to EPS of $-0.15 on revenue of $51.1M in the same period a year before. Hutchison China MediTech had reported EPS of $-0.22 on revenue of $52.32M in the previous quarter. Analysts are expecting EPS of $-0.32 and revenue of $57.31M in the upcoming quarter.
Hutchison China MediTech shares are down 8.34% from the beginning of the year , still down 24.16% from its 52 week high of $30.30 set on June 27, 2019. They are under-performing the Nasdaq which is up 7.12% year to date.
Hutchison China MediTech follows other major sector earnings this month
Hutchison China MediTech's report follows an earnings beat by Tencent ADR on May 13, who reported EPS of $0.42 on revenue of $15.23B, compared to forecasts EPS of $0.33 on revenue of $14.28B.
SoftBank Group had missed expectations on May 18 with first quarter EPS of $-3.23 on revenue of $14.72B, compared to forecast for EPS of $-0.71 on revenue of $23.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
